期刊文献+

肺表面活性物质预防早产儿呼吸窘迫综合征的疗效评价 被引量:8

Efficacy of pulmonary surfactant for prevention of neonatal respiratory distress syndrome of preterm infants
下载PDF
导出
摘要 目的评价肺表面活性物质(pulmonary surfactant,PS)预防早产儿呼吸窘迫综合征(neonatal respiratory distress syndrome,NRDS)的疗效。方法95例胎龄为28~34周早产儿,均给予保暖、通畅呼吸道、吸氧、呼吸机辅助呼吸、控制感染、防治出血等常规治疗的基础上,按照家长对PS的使用意见分为两组。观察治疗组45例,出现典型临床表现确诊为NRDS后使用PS,若未出现典型临床表现,则不使用PS;预防使用组50例,全部在出生后30分钟内,无论有无NRDS的临床表现均使用PS。比较两组患儿NRDS发生率、胸部X射线、辅助呼吸时间、并发症率和病死率。结果预防使用组的NRDS发生率(38.00%)明显低于观察治疗组(75.56%),确诊病例较观察治疗组的胸片分级低,辅助呼吸时间短,差异均有统计学意义(P〈0.05)。两组并发症发生率及病死率差异无统计学意义(P〉0.05)。结论与观察确诊后才使用PS相比,早期预防使用PS能够减少NRDS的发生率,降低胸片分级,缩短辅助呼吸时间。 Objective To evaluate the effects of pulmonary surfactant(PS) for prevention of neonatal respiratory distress syndrome (NRDS) of preterm infants, Methods Clinical data of 95 preterm infants with gestational age ranged from 28 to 34 weeks were retrospectively analyzed. All eases were given a conventional treatment, such as a warm, airway patency, oxygen supply, mechanical ventilation, infection control and prevention or controlling hemorrhage. The infants were divided into observation group( n = 45 )and prevention group( n =50)according to the decision of the parents. In the observation group,PS was given when the typical clinical manifestations were diagnosed as NRDS, otherwise no PS was applied. In the prevention group PS was administrated after 30 min of birth regardless of the clinical manifestations of NRDS. The incidence of NRDS, chest X ray examination, time of mechanical ventilation, complica- tion and mortality rate were compared between the two groups. Results The incidence of NRDS in the prevention group(38.0% )was significantly lower than that in the observation group(75.56% ). In the NRDS confirmed cases, grade of chest X-ray was lower and time of mechanical ventilation was longer in the observation group than that in the prevention group( all P 〈 0. 05 ). No significant difference in the rates of complications and mortality between the two groups. Conclusion Early administration of PS for prevention of NRDS can reduce the diseases incidence,lower the grade of chest X-ray, shorten the time of mechanical ventilation in NRDS cases. However, the complication rate and mortality have not been significantly improved yet.
出处 《实用医院临床杂志》 2014年第2期77-79,共3页 Practical Journal of Clinical Medicine
关键词 肺表面活性物质 新生儿呼吸窘迫综合征 早产儿 预防 Pulmonary surfactant Respiratory distress syndrome Preterm infant Prevention
  • 相关文献

参考文献13

  • 1史学凯,吴时光,罗晓鸿,蓝国锋,柳国胜.鼻塞持续呼吸道正压通气与机械通气治疗Ⅳ级新生儿呼吸窘迫综合征的疗效[J].实用儿科临床杂志,2010,25(2):123-124. 被引量:25
  • 2Sweet DG,Camielli V,Greisen G,et al.European consensus guide-lines on the management of neonatal respiratory distress syndrome inpreterm infants-2010 update[J].Neonatology,2010,97(4); 402-417.
  • 3Dani C,Barp J,Berti E,et ai.Surfactant in the preterm infant:what’sgoing on[J].Matem Fetal Neonatal Med,2009,22(Suppl)3:3-5.
  • 4邵肖梅,叶鸿瑁,丘小汕.实用新生儿学[M].第4版.北京:人民卫生出版社,2011:872.
  • 5Ikegami M,Weaver TE,Grant SN,et al.Pulmonary surfactant surfac-etension influences alveOlar capillary shape and oxygenation[J].Am J Respir Cell Mol Biol,2009,41(4):433-439.
  • 6Olmeda B,Vill6n L5Cruz A,et al.Pulmonary sutiifachant layers ac-celerate 0(2)diffiasion through the air-water interface[J].BiochimBiophys Acta,2010,1798(6):1281-1284.
  • 7Nkadi PO,Merrintt TA,Pillers DA.An overview of pulmonary surf-ctant in the neonate:genetics,metabolism,and the role of surfactantin health and disease[J].Mol Genet Metab,2009,97(2):95-101.
  • 8刘畅,李建国.急性呼吸窘迫综合征:新定义与新进展[J].实用医院临床杂志,2012,9(6):15-19. 被引量:2
  • 9Soil RF.Current trials in the treatment of respiratory failure in pre-term infants[J].Neonatology,2009,95(4):368-372.
  • 10Stevens TP,Harrington EW,Blennow M,et al.Early surfactant ad-ministration with brief ventilation vs selective surfactant and contin-ued mechanical ventilation for preterm infants with or at risk for re-spiratory distress syndrome[J].Cochrane Database Syst Rev,2007,17(4):CD003063.

二级参考文献60

  • 1金汉珍,黄德珉,官希吉.实用新生儿科学[M].3版.北京:人民卫生出版社,2001:461-465.
  • 2Morley C, Davis P. Continuous positive airway pressure : Current controversies [ J]. Curr Opin Pediatr ,2004 ,16 ( 3 ) : 141 - 145.
  • 3May M, Strobel P, Preisshofen T, et al. Apoptosis and proliferation in lungs of ventilated and oxygen - treated preterm infants [ J ]. Eur Respir J,2004,23(1) : 113 - 121.
  • 4Otto CM, Markstal.ler K, Kajikawa O, et al. Spatial and temporal heterogeneity of ventilator - associated lung injury after surfactant depletion [ J]. Appl Physiol,2008,104 ( 5 ) : 1485 - 1494.
  • 5Ziora D. Serum biomarkers in idiopathic pulmonary fibrosis[ J]. Pneumonol Alergol Pol, 2007,75 ( 3 ) :268 - 272.
  • 6Suzuki Y, Yamamoto T, Kojima K, et al. Evaluation levels of cytokines in amniotic fluid of women with intrauterine infection in the early second trimester[ J]. Fetal Diagn Ther ,2006 ,21 ( 1 ) : 45 - 50.
  • 7Govindaraju V, Michoud MC, Ferraro P,et al. The effects of interleukin- 8 on airway smooth muscle contraction in cystic fibrosis [ J ]. Respir Res, 2008,9:76.
  • 8Su BH, Chiu HY, Lin TW, et al. Interleukin - 8 in bronchoalveolar lavage fluid of premature infants at risk of chronic lung disease [ J ]. J Formos Med Assoc,2005,104 (4) : 244 - 248.
  • 9Ishitsuka Y,Moriuchi H, Isohama Y,et al. A selective thromboxane A2 ( TXA2 ) synthase inhibitor, ozagrel, attenuates lung injury and decreases monocyte chemoattractant protein - 1 and interleukin - 8 mRNA expression in oleic acid - induced lung injury in guinea pigs[ J]. Pharmacol Sci,2009,111(2) :211 -215.
  • 10Bautista MV, Chen Y, Ivanova VS, et al. IL -8 regulates mucin gene expression at the posttranscriptional level in lung epithelial cells[ J ]. J Immunol,2009,183 ( 3 ) :2159 - 2166.

共引文献408

同被引文献91

  • 1单红梅,蔡威,陶晔璇,汤庆娅.早产儿宫外生长发育迟缓的评价[J].中国临床营养杂志,2005,13(3):150-153. 被引量:17
  • 2柳洁,王莉,孙健梅.固尔苏预防早产儿呼吸窘迫综合征的临床研究[J].中国新生儿科杂志,2007,22(3):139-141. 被引量:40
  • 3邵肖梅,叶鸿瑁,丘小汕.实用新生儿学[M].第4版.北京:人民卫生出版社,2011:872.
  • 4邵肖梅,叶鸿瑶,丘小汕.实用新生儿学[M].4版.北京:人民卫生出版社,2011:807-808.
  • 5Jennifer S Landry,Dick Menzies. Occurrence and severity of bronchopulmonary dysplasia and respiratory distress syn- drome after a preterm birth[J]. Paediatrics & Child Health, 2011,16(7) :399-403.
  • 6William M Callaghan, Andreea A Creanga,E|ena V Kuk- lina.Severe maternal morbidity among delivery and post- paitum hospitalizations in the United States[J]. Obstetrics and Gynecology, 2012, 120(5) : 1029-1036.
  • 7Evangelia Akoumianaki,Aissam Lyazidi,Nathalie Rey. Me- chanical ventilation-induced reverse-triggered breaths:A frequently unrecognized form of neuromechanical coupling[J]. Chest, 2013,143 (4) : 927-938.
  • 8Brian R Jacobs,Vinay Nadkarni,Brahm Goldstein. Nutri- tional immunomodulation in critically ill children with a- cute lung injury:Feasibility and impact on circulating biomarkers[J]. Pediatric Critical Care Medicine,2013,14 (1) :45-56.
  • 9Steven MD, Jennifer D. Surfactant replacement therapy in the neo- nate :beyond respiratory distress syndrome [J]. Resp Care,2009,54 (9) :1203-1208.
  • 10蹇常娥,姜玲.肺表面活性物质新法给药方式的效果观察[J].中国实用护理杂志(下旬版),2008,24(2):36-38. 被引量:5

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部